http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H04211093-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-572
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
filingDate 1991-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f649724d6804bac3e2c35c268dab4da2
publicationDate 1992-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H04211093-A
titleOfInvention Selective preparation of fosinopril polymorph
abstract Described herein is a process for selectively preparing and interconverting polymorph salts of fosinopril, an antihypertensive agent that inhibits angiotensin converting enzyme. Each polymorph is prepared by mixing an alkali metal carrier, fosinopril, water and a keto and/or hydroxylic solvent and isolating the polymorph formed from the reaction mixture. The less exothermic polymorph A is formed when the water makes up more than about 0.2% of the water and solvents; at about 0.2% or less, the more exothermic polymorph B is formed. <IMAGE>
priorityDate 1990-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16051939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405956
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405957
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55891
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58666458
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405955

Total number of triples: 20.